Literature DB >> 30988110

Ceftriaxone-induced leucocytoclastic vasculitis.

Daniela Andrea Haehn1, Archi Patel2, George Youngberg2, Alexei Gonzalez-Estrada3.   

Abstract

Entities:  

Keywords:  dermatology; skin

Mesh：

Substances：

Year:  2019        PMID： 30988110      PMCID： PMC6506085          DOI： 10.1136/bcr-2019-229411

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

Review 1.  A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis.

Authors:  Megan R Goeser; Valerie Laniosz; David A Wetter
Journal:  Am J Clin Dermatol       Date:  2014-08       Impact factor: 7.403

Review 2.  Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients.

Authors:  R Blanco; V M Martínez-Taboada; V Rodríguez-Valverde; M García-Fuentes
Journal:  Medicine (Baltimore)       Date:  1998-11       Impact factor: 1.889

3.  Demographic characteristics, aetiology, and assessment of treatment options in leukocytoclastic vasculitis.

Authors:  Alkim Unal Cakiter; Ozlem Su Kucuk; Dilek Biyik Ozkaya; Bugce Topukcu; Nahide Onsun
Journal:  Postepy Dermatol Alergol       Date:  2017-04-13       Impact factor: 1.837
  3 in total
  3 in total

Review 1.  Ceftriaxone-induced leukocytoclastic vasculitis: a case report and literature review of antibiotic-induced leukocytoclastic vasculitis.

Authors:  Aseel A Almasoudi; Eman S Bablghaith; Samaher I Alaauldeen; Ayman M Falemban; Ahlam A Sherbeeni; Adeeb A Bulkhi
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

2.  Cephalexin-Induced Leukocytoclastic Vasculitis.

Authors:  Wesley Tang; Jennie Tan
Journal:  Cureus       Date:  2022-07-04

3.  The Dark Purple Side of Ceftriaxone: A Case Report on Leucocytoclastic Vasculitis.

Authors:  Elia Rigamonti; Francesca Bedussi; Jerome Blanc; Pietro Gianella; Gianluca Vanini
Journal:  Eur J Case Rep Intern Med       Date:  2020-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.